<code id='9F188B05D5'></code><style id='9F188B05D5'></style>
    • <acronym id='9F188B05D5'></acronym>
      <center id='9F188B05D5'><center id='9F188B05D5'><tfoot id='9F188B05D5'></tfoot></center><abbr id='9F188B05D5'><dir id='9F188B05D5'><tfoot id='9F188B05D5'></tfoot><noframes id='9F188B05D5'>

    • <optgroup id='9F188B05D5'><strike id='9F188B05D5'><sup id='9F188B05D5'></sup></strike><code id='9F188B05D5'></code></optgroup>
        1. <b id='9F188B05D5'><label id='9F188B05D5'><select id='9F188B05D5'><dt id='9F188B05D5'><span id='9F188B05D5'></span></dt></select></label></b><u id='9F188B05D5'></u>
          <i id='9F188B05D5'><strike id='9F188B05D5'><tt id='9F188B05D5'><pre id='9F188B05D5'></pre></tt></strike></i>

          Wikipedia

          knowledge

          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more
          AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B
          AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

          RubyWallauforSTATAbbViewillpay$10billionforthebiotechfirmImmunogen,thecompanysaidThursday,acquiringa

          read more
          Bright Health sells Medicare Advantage business to Molina
          Bright Health sells Medicare Advantage business to Molina

          BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

          read more

          The UK government moves asylum

          1:27PoliceofficersstandguardoutsidePortlandPortbeforethefirstasylumseekersarrivetoboardtheBibbyStock